We published our findings in 2016 showing that the depletion of USP10 confers cellular resistance to both drugs, 6-TG (6-thioganuine) and MNNG (N-methyl-N’nitro-N-nitrosoguanidine), in NSCLC cells due to the decreased level of MSH2 [20]. Here, USP10 is linked to non-small cell lung carcinoma.